Evommune Stock Forecast

Hold candidate since Aug 06, 2026 Gain 5.16%

The Evommune, Inc. stock price fell by -0.0710% on the last day (Monday, 10th Aug 2026) from $14.08 to $14.07. During the last trading day the stock fluctuated 5.19% from a day low at $13.59 to a day high of $14.30. The price has been going up and down for this period, and there has been a 22.67% gain for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -158 thousand shares and in total, 216 thousand shares were bought and sold for approximately $3.04 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -44.24% during the next 3 months and, with a 90% probability hold a price between $5.12 and $10.14 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

EVMN Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, July 29, 2026, and so far it has risen 27.33%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Evommune, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $14.09. On a fall, the stock will find some support from the short-term average at $12.93. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Evommune, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $13.34 and $13.29. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Evommune, Inc. finds support just below today's level at $13.34. If this is broken, then the next support from accumulated volume will be at $13.29 and $12.82.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.706 between high and low, or 5.19%. For the last week, the stock has had daily average volatility of 6.57%.

Our recommended stop-loss: $13.56 (-3.62%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 8 days ago.)

Trading Expectations (EVMN) For The Upcoming Trading Day Of Tuesday 11th

For the upcoming trading day on Tuesday, 11th we expect Evommune, Inc. to open at $13.99, and during the day (based on 14 day Average True Range), to move between $13.56 and $14.58, which gives a possible trading interval of +/-$1.02 (+/-7.54%) up or down from last closing price. If Evommune, Inc. takes out the full calculated possible swing range there will be an estimated 7.54% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $14.08 (0.07%) than the support at $13.34 (5.19%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Evommune, Inc. stock A Buy?

Evommune, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.222 Hold/Accumulate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 11, 2026 - $13.99 ( 0.602%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk